Tower Research Capital LLC (Trc) Harvard Bioscience Inc Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,005 shares of HBIO stock, worth $6,520. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,005

Previous 13,760 78.16%

Holding current value

$6,520

Previous $39,000 79.49%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$2.64 - $3.54 $28,393 - $38,072	-10,755 Reduced 78.16%	3,005 $8,000
Q2 2024 Aug 13, 2024	BUY	$2.77 - $4.63 $37,079 - $61,977	13,386 Added 3579.14%	13,760 $39,000
Q1 2024 May 15, 2024	SELL	$4.02 - $5.39 $9,611 - $12,887	-2,391 Reduced 86.47%	374 $1,000
Q4 2023 Feb 13, 2024	SELL	$4.0 - $5.49 $1,736 - $2,382	-434 Reduced 13.57%	2,765 $14,000
Q3 2023 Nov 14, 2023	SELL	$4.0 - $5.82 $37,120 - $54,009	-9,280 Reduced 74.36%	3,199 $13,000
Q2 2023 Aug 14, 2023	BUY	$4.19 - $6.16 $52,287 - $76,870	12,479 New	12,479 $68,000
Q3 2022 Nov 10, 2022	BUY	$2.33 - $3.92 $6,300 - $10,599	2,704 Added 257.28%	3,755 $9,000
Q2 2022 Aug 15, 2022	SELL	$3.28 - $6.42 $92,630 - $181,307	-28,241 Reduced 96.41%	1,051 $4,000
Q1 2022 May 12, 2022	BUY	$5.16 - $7.14 $2,610 - $3,612	506 Added 1.76%	29,292 $182,000
Q4 2021 Feb 14, 2022	BUY	$6.37 - $8.18 $164,995 - $211,878	25,902 Added 898.13%	28,786 $203,000
Q3 2021 Nov 15, 2021	BUY	$6.98 - $8.47 $7,335 - $8,901	1,051 Added 57.34%	2,884 $20,000
Q2 2021 Aug 16, 2021	SELL	$5.44 - $8.4 $19,698 - $30,416	-3,621 Reduced 66.39%	1,833 $15,000
Q1 2021 May 17, 2021	SELL	$3.91 - $6.99 $17,821 - $31,860	-4,558 Reduced 45.53%	5,454 $30,000
Q4 2020 Feb 16, 2021	SELL	$3.0 - $4.5 $80,127 - $120,190	-26,709 Reduced 72.73%	10,012 $43,000
Q3 2020 Nov 16, 2020	BUY	$2.75 - $4.2 $80,605 - $123,106	29,311 Added 395.56%	36,721 $110,000
Q2 2020 Aug 13, 2020	BUY	$2.12 - $3.14 $15,497 - $22,953	7,310 Added 7310.0%	7,410 $23,000
Q1 2020 May 15, 2020	SELL	$1.42 - $3.29 $1,537 - $3,563	-1,083 Reduced 91.55%	100 $0
Q4 2019 Feb 07, 2020	BUY	$2.45 - $3.25 $2,729 - $3,620	1,114 Added 1614.49%	1,183 $3,000
Q3 2019 Nov 05, 2019	SELL	$1.59 - $3.47 $21,755 - $47,480	-13,683 Reduced 99.5%	69 $0
Q2 2019 Aug 13, 2019	BUY	$1.93 - $4.59 $21,251 - $50,540	11,011 Added 401.71%	13,752 $28,000
Q1 2019 May 14, 2019	SELL	$2.77 - $4.38 $7,129 - $11,274	-2,574 Reduced 48.43%	2,741 $12,000
Q4 2018 Feb 14, 2019	SELL	$3.03 - $5.0 $542 - $895	-179 Reduced 3.26%	5,315 $17,000
Q3 2018 Nov 13, 2018	BUY	$5.0 - $6.65 $27,470 - $36,535	5,494 New	5,494 $29,000
Q2 2018 Aug 15, 2018	SELL	$4.2 - $5.95 $21,537 - $30,511	-5,128 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$3.3 - $5.15 $16,922 - $26,409	5,128 New	5,128 $26,000

Others Institutions Holding HBIO

# of Institutions

Shares Held

31.5M

Call Options Held

700

Put Options Held

2.1K

View Full List

About HARVARD BIOSCIENCE INC

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $90.4M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

More about HBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Harvard Bioscience Inc Transaction History